Literature DB >> 11266270

Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation.

T R Howdieshell1, D Callaway, W L Webb, M D Gaines, C D Procter, J S Pollock, T L Brock, P L McNeil.   

Abstract

OBJECTIVE: The goal of this work was to test the functional role of vascular endothelial growth factor (VEGF) in promoting the vigorous granulation tissue formation, wound fluid accumulation, and angiogenic responses characteristic of this wound model.
BACKGROUND: Formation of vessel-rich granulation tissue is central to wound repair and is thought to be regulated by locally liberated angiogenic factors. Despite the clinical importance of granulation tissue formation in the early stage of wound healing, surprisingly little is known about the molecular identity of signals leading to granulation tissue invasion of a wound space. Methods. A ventral hernia, surgically created in the abdominal wall of 15 swine, was repaired using silicone sheeting and skin closure. An osmotic minipump, inserted in a remote subcutaneous pocket, delivered saline (n = 5), an irrelevant control antibody (n = 5), or neutralizing anti-VEGF antibody (n = 5) into the wound environment. Serial ultrasonography on Days 2, 4, 7, 9, 11, and 14 was used to determine the dimensions of the subcutaneous granulation tissue and wound fluid compartment. VEGF and transforming growth factor beta1 (TGF-beta1) levels in serial wound fluid samples were quantitated by ELISA. On Day 14, animals were sacrificed and the abdominal wall was harvested for histologic, biochemical, and molecular analyses.
RESULTS: In animals receiving saline or an irrelevant antibody, a nearly linear 4-fold increase in granulation tissue thickness and 7-fold increase in wound fluid volume were measured over the 14-day study interval. In contrast, in animals receiving anti-VEGF neutralizing antibody, Day 14 granulation tissue thickness and wound fluid volume measurements were essentially unchanged from Day 2 values. Moreover, in the anti-VEGF animals, ultrasonography was unable to resolve the "angiogenic zone" typical of both controls, and correspondingly, wound vessel count and vascular surface area estimates derived from image analysis of histological sections were 3-fold lower in the anti-VEGF animals compared with the saline and antibody controls. Finally, VEGF levels in wound fluid detectable by ELISA analysis were strikingly (10-fold) reduced in anti-VEGF animals on Postsurgery Days 7-14. In contrast, TGF-beta1 levels were unaffected by the anti-VEGF treatment.
CONCLUSION: Functional VEGF is a key mediator in wound angiogenesis, fluid accumulation, and granulation tissue formation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11266270     DOI: 10.1006/jsre.2001.6089

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  31 in total

Review 1.  Treatment of metastatic renal cell carcinoma.

Authors:  Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Pierre I Karakiewicz
Journal:  Nat Rev Urol       Date:  2010-05-11       Impact factor: 14.432

Review 2.  Cytokine orchestration in post-operative peritoneal adhesion formation.

Authors:  Ronan A Cahill; H Paul Redmond
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

3.  Collagen-based sponge hastens wound healing via decrease of inflammatory cytokines.

Authors:  Adithan Aravinthan; Jeong-Kyu Park; Mohammad Amjad Hossain; Judith Sharmila; Han-Jong Kim; Chang-Won Kang; Nam Soo Kim; Jong-Hoon Kim
Journal:  3 Biotech       Date:  2018-11-16       Impact factor: 2.406

Review 4.  Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy.

Authors:  Erqi L Pollom; Lei Deng; Reetesh K Pai; J Martin Brown; Amato Giaccia; Billy W Loo; David B Shultz; Quynh Thu Le; Albert C Koong; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-01       Impact factor: 7.038

5.  Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing.

Authors:  David C Turner; Fariba Navid; Najat C Daw; Shenghua Mao; Jianrong Wu; Victor M Santana; Michael Neel; Bhaskar Rao; Jennifer Reikes Willert; David M Loeb; K Elaine Harstead; Stacy L Throm; Burgess B Freeman; Clinton F Stewart
Journal:  Clin Cancer Res       Date:  2014-03-17       Impact factor: 12.531

6.  Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse.

Authors:  M Galeano; B Deodato; D Altavilla; D Cucinotta; N Arsic; H Marini; V Torre; M Giacca; F Squadrito
Journal:  Diabetologia       Date:  2003-04-02       Impact factor: 10.122

7.  Serum VEGF and b-FGF profiles after tension-free or conventional hernioplasty.

Authors:  Gaetano Di Vita; Rosalia Patti; Pietro D'Agostino; Francesco Arcoleo; Giuseppe Caruso; Matteo Arcara; Valentina Davì; Enrico Cillari
Journal:  Langenbecks Arch Surg       Date:  2005-09-23       Impact factor: 3.445

Review 8.  microRNA-200b as a Switch for Inducible Adult Angiogenesis.

Authors:  Mithun Sinha; Subhadip Ghatak; Sashwati Roy; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2015-05-10       Impact factor: 8.401

9.  [Bevacizumab (Avastin) related surgical complications: comment to Abbrederis K et al. (2007)].

Authors:  F Lordick; J R Siewert
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

10.  Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future.

Authors:  John S P Yuen
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.